Relationship between DNA Methylation in the 5' CpG Island of the SLC47A1 (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human Liver.

Molecular Pharmacology
Toshihiro TanakaIchiro Ieiri

Abstract

Multidrug and toxin extrusion protein 1 (MATE1), which is encoded by solute carrier 47A1 (SLC47A1), mediates the excretion of organic cations into bile and urine. Some genetic variants in human MATE1 altered its transport function in in vitro experiments; however, differences in the pharmacokinetics of substrate drugs cannot be explained by genetic variations in humans. In this study, we investigated whether DNA methylation was involved in interindividual variability in MATE1 expression in the human liver. Approximately 20-fold interindividual variability in MATE1 mRNA expression levels was observed in liver samples and mRNA expression levels negatively correlated with methylation levels of the CpG island in the 27 kb upstream of SLC47A1 DNA demethylation by treatment with 5-aza-2'-deoxycytidine increased MATE1 mRNA expression in MATE1-negative cell lines. The luciferase reporter assay showed that the CpG island increased the transcriptional activity of the SLC47A1 promoter. MATE1 mRNA expression levels were significantly lower in CpG island knockout HepG2 cells than in control cells. These results suggest that the 5' CpG island of SLC47A1 acts as an enhancer for SLC47A1, and DNA methylation in the CpG island plays an important...Continue Reading

References

Dec 26, 2001·Nature Genetics·Bong June YoonPaul D Soloway
Jan 10, 2002·Genes & Development·Adrian Bird
Oct 2, 2004·Human Molecular Genetics·Takeshi HirotaKenji Otsubo
Apr 22, 2005·British Journal of Clinical Pharmacology·Mikko NiemiMartin F Fromm
Nov 30, 2005·Molecular and Cellular Biology·Bongjune YoonPaul D Soloway
Dec 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Masato OtsukaYoshinori Moriyama
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Serge SaxonovDouglas L Brutlag
Sep 7, 2006·Molecular and Cellular Biology·Kenneth K W ToSusan E Bates
Feb 14, 2007·Biochemical Pharmacology·Kumiko NishiharaKen-Ichi Inui
Jul 21, 2007·Nature Protocols·Hélène HagègeThierry Forné
Sep 15, 2007·American Journal of Physiology. Renal Physiology·Moto KajiwaraKen-ichi Inui
May 30, 2008·American Journal of Physiology. Renal Physiology·Masayo AokiKen-ichi Inui
Dec 19, 2009·Neoplasia : an International Journal for Oncology Research·Eran E BramYehuda G Assaraf
May 18, 2011·Genes & Development·Aimée M Deaton, Adrian Bird
Oct 4, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Satoki ImaiYuichi Sugiyama
Dec 27, 2012·Clinical Pharmacology and Therapeutics·S L StockerK M Giacomini
Apr 6, 2013·Biochemical and Biophysical Research Communications·Tae Hee KimJi Ha Choi
Nov 9, 2014·Human Molecular Genetics·Danxin WangXiaochun Sun
May 20, 2015·Frontiers in Molecular Biosciences·Kristina Warton, Goli Samimi
Oct 8, 2015·Genes & Development·Kiwon LeeGerd A Blobel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.